使用嵌合病毒的人类抗埃博拉疫苗:理性的希望

IF 0.7 4区医学 Q4 VIROLOGY

Virologie Pub Date : 2015-09-01 DOI:10.1684/VIR.2015.0621

D. Gerlier

{"title":"使用嵌合病毒的人类抗埃博拉疫苗:理性的希望","authors":"D. Gerlier","doi":"10.1684/VIR.2015.0621","DOIUrl":null,"url":null,"abstract":"The promising ability of a recombinant vaccine to protect humans against the risk of getting infected upon contact with Ebola-sick patients comes as one of the best news from the recent devastating Ebola crisis in Western Africa [1]. This trial is built according to the ring vaccination scheme that was used in the final stage of the smallpox eradication scheme [2] (figure 1). This scheme was developed to curtail the limitations of mass vaccination and to reduce exposure to the risk of severe side [...]","PeriodicalId":49377,"journal":{"name":"Virologie","volume":"18 1","pages":"1-7"},"PeriodicalIF":0.7000,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anti-Ebola vaccination of humans using a chimeric virus: rational of a hope\",\"authors\":\"D. Gerlier\",\"doi\":\"10.1684/VIR.2015.0621\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The promising ability of a recombinant vaccine to protect humans against the risk of getting infected upon contact with Ebola-sick patients comes as one of the best news from the recent devastating Ebola crisis in Western Africa [1]. This trial is built according to the ring vaccination scheme that was used in the final stage of the smallpox eradication scheme [2] (figure 1). This scheme was developed to curtail the limitations of mass vaccination and to reduce exposure to the risk of severe side [...]\",\"PeriodicalId\":49377,\"journal\":{\"name\":\"Virologie\",\"volume\":\"18 1\",\"pages\":\"1-7\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2015-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Virologie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1684/VIR.2015.0621\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"VIROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virologie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1684/VIR.2015.0621","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"VIROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

重组疫苗有希望保护人类在接触埃博拉患者后免受感染的风险，这是最近西非毁灭性的埃博拉危机带来的最好消息之一[1]。该试验是根据天花根除计划最后阶段使用的环形疫苗接种计划建立的[2](图1)。该计划旨在减少大规模疫苗接种的局限性，并减少暴露于严重副作用的风险[…]

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Anti-Ebola vaccination of humans using a chimeric virus: rational of a hope

The promising ability of a recombinant vaccine to protect humans against the risk of getting infected upon contact with Ebola-sick patients comes as one of the best news from the recent devastating Ebola crisis in Western Africa [1]. This trial is built according to the ring vaccination scheme that was used in the final stage of the smallpox eradication scheme [2] (figure 1). This scheme was developed to curtail the limitations of mass vaccination and to reduce exposure to the risk of severe side [...]

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Virologie VIROLOGY-

CiteScore

1.20

自引率

22.20%

发文量

审稿时长

>12 weeks

期刊介绍： Virologie offers top-level information for all those for whom virology is already the main or an important part of their activity: biologists, clinicians, pharmacists, veterinarians, agronomists, etc.